Quarterly report pursuant to Section 13 or 15(d)

DERIVATIVE FINANCIAL INSTRUMENTS AND WARRANT LIABILITIES (Tables)

v3.24.2.u1
DERIVATIVE FINANCIAL INSTRUMENTS AND WARRANT LIABILITIES (Tables)
6 Months Ended
Jun. 30, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of assumptions
           
    May 24, 2023     August 3, 2023  
Conversion Feature Liabilities                
Company stock price on valuation date   $ 15,750.00     $ 12,397.50  
Volatility (closing prices of guideline comparable public companies)     86.3%       84.1%  
Conversion price per share   $ 16,875.00     $ 16,875.00  
Note term (years)     0.76       0.56  
Risk free interest rate     5.1%       5.4%  
                 
Warrant Liabilities                
Company stock price on valuation date   $ 15,750.00     $ 12,397.50  
Volatility (closing prices of guideline comparable public companies)     119.2%       115.0%  
Conversion price per share   $ 16,875.00     $ 16,875.00  
Warrant term (years)     4.25       4.06  
Risk free interest rate     3.8%       4.3%  
Schedule of fair value of derivative liabilities
           
    May 24, 2023     August 3, 2023  
Conversion Feature - New Notes   $ 663,096     $ 557,168  
Conversion Feature - Series A Exchange Notes     970,805       416,672  
Conversion Feature - Series B Exchange Notes     4,324,792       2,651,436  
New Warrants     3,123,682       2,445,244  
Exchange Warrants     9,287,474       7,191,535  
Total   $ 18,369,849     $ 13,262,055  
Schedule of warrants assumptions
     
    December 31, 2023  
       
Company stock price on valuation date   $ 4.46  
Volatility     141.4%  
Risk free interest rate     3.78%  
Dividend yield     0.00%  
Warrant term (years)     4.9  
Time to future transaction (years)     0.63  
Future transaction probability     75%  
Schedule of estimated fair value of warrant liabilities
     
    December 31, 2023  
Series A Warrant   $ 0.2970  
Series B Warrant   $ 0.0799  
Schedule of derivative activity
                 
    Series A     Series B     Total  
Fair value on December 31, 2023   $ 4,705,245     $ 1,265,822     $ 5,971,067  
Loss on changes in fair value     12,718,378       2,174,673       14,893,051  
Exercise of warrants     (17,352,653 )     (34,833 )     (17,387,486 )
Reclassification to equity           (3,405,662 )     (3,405,662 )
Balance at June 30, 2024   $ 70,970     $     $ 70,970